Navigating COVID-19 in the cannabis industry

Navigating COVID-19 in the cannabis industry

“Several laboratory studies indicate that cannabinoid compounds – in particular, cannabidiol (CBD) and tetrahydrocannabinol (THC) – are immunosuppressant and may have anti-viral effects. The interplay between cannabinoids and the immune system is intricate, adaptive, and bidirectional.

The International Association for Cannabinoid Medicine (IACM), based in Germany, issued a statement on the COVID-19 pandemic saying, “there is no evidence that individual cannabinoids or cannabis preparations protect against infection … or could be used to treat COVID-19”. Clinical trials have been launched in Israel to explore whether CBD’s anti-inflammatory properties can be an effective COVID-19 treatment. Until this has been clinical” 

 

Leave a Reply

Your email address will not be published.